MetLife (MET) Stock Overview
A financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 5/6 |
MET Community Fair Values
Create NarrativeSee what 35 others think this stock is worth. Follow their fair value or set your own to get alerts.
MetLife, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$80.82 |
| 52 Week High | US$89.05 |
| 52 Week Low | US$65.21 |
| Beta | 0.86 |
| 1 Month Change | 4.51% |
| 3 Month Change | 3.09% |
| 1 Year Change | 6.08% |
| 3 Year Change | 24.19% |
| 5 Year Change | 103.73% |
| Change since IPO | 447.93% |
Recent News & Updates
Recent updates
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Jun 11
MetLife's New Frontier: Hidden Growth Opportunities
May 03MetLife's (NYSE:MET) Dividend Will Be Increased To $0.5675
Apr 26MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Feb 11Investors Continue Waiting On Sidelines For MetLife, Inc. (NYSE:MET)
Jan 14MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Nov 26MetLife, Inc.'s (NYSE:MET) P/E Still Appears To Be Reasonable
Sep 24MetLife: One Of The Best Life Insurance Stocks
Sep 23Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Jul 09MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Jun 26MetLife: Healthy But Lacks Clear Advantages
Apr 18MetLife: A Safe Bet To Hold As Future Earnings Growth Expected, And Tailwind From Rate Environment
Feb 03MetLife: Expected Net Investment Growth For Upcoming Earnings
Jan 26MetLife: Strong Capital Returns Make Shares Attractive (Ratings Upgrade)
Nov 15MetLife: Disappointing Growth But Safe Dividend
Oct 26MetLife: Neutral Rating Maintained, As Stock Remains Overvalued
Aug 18MetLife: An Investment That Ensures Portfolios
Jul 12Shareholder Returns
| MET | US Insurance | US Market | |
|---|---|---|---|
| 7D | 1.6% | 0.7% | 1.7% |
| 1Y | 6.1% | 1.9% | 18.7% |
Return vs Industry: MET exceeded the US Insurance industry which returned 1.9% over the past year.
Return vs Market: MET underperformed the US Market which returned 18.5% over the past year.
Price Volatility
| MET volatility | |
|---|---|
| MET Average Weekly Movement | 2.9% |
| Insurance Industry Average Movement | 4.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MET has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: MET's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 45,000 | Michel Khalaf | www.metlife.com |
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
MetLife, Inc. Fundamentals Summary
| MET fundamental statistics | |
|---|---|
| Market cap | US$53.75b |
| Earnings (TTM) | US$4.09b |
| Revenue (TTM) | US$73.01b |
Is MET overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MET income statement (TTM) | |
|---|---|
| Revenue | US$73.01b |
| Cost of Revenue | US$54.23b |
| Gross Profit | US$18.78b |
| Other Expenses | US$14.69b |
| Earnings | US$4.09b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.15 |
| Gross Margin | 25.73% |
| Net Profit Margin | 5.60% |
| Debt/Equity Ratio | 171.7% |
How did MET perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/14 14:54 |
| End of Day Share Price | 2025/09/12 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MetLife, Inc. is covered by 38 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jacob Kilstein | Argus Research Company |
| John Heagerty | Atlantic Equities LLP |
| Ishan Majumdar | Baptista Research |